Construction of a prognostic risk score model based on the ARHGAP family to predict the survival of osteosarcoma

被引:0
作者
Wenda Liu
Kezhou Xia
Di Zheng
Xinghan Huang
Zhun Wei
Zicheng Wei
Weichun Guo
机构
[1] Renmin Hospital of Wuhan University,Department of Orthopaedics
来源
BMC Cancer | / 23卷
关键词
Osteosarcoma; Prognosis model; Immune pathway infiltration; family genes; Individualized treatment;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 320 条
[1]  
Meltzer PS(2021)New Horizons in the Treatment of Osteosarcoma N Engl J Med 385 2066-2076
[2]  
Helman LJ(2022)Current Status and Prospects of Clinical Treatment of Osteosarcoma Technol Cancer Res Treat 21 15330338221124696-790
[3]  
Jiang ZY(2002)Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols J Clin Oncol 20 776-1109
[4]  
Liu JB(2005)Metastatic osteosarcoma at diagnosis: prognostic factors and long-term outcome–the French pediatric experience Cancer 104 1100-50
[5]  
Wang XF(2018)Current and future therapeutic approaches for osteosarcoma Expert Rev Anticancer Ther 18 39-522
[6]  
Ma YS(2009)Primary osteogenic sarcoma with pulmonary metastasis: clinical results and prognostic factors in 91 patients Jpn J Clin Oncol 39 514-193
[7]  
Fu D(2018)Osteosarcoma, Chondrosarcoma, and Chordoma J Clin Oncol 36 188-635
[8]  
Bielack SS(2002)Paving the Rho in cancer metastasis: Rho GTPases and beyond Rho GTPases in cell biology Nature 420 629-21
[9]  
Kempf-Bielack B(2018)Current knowledge of the large RhoGAP family of proteins Pharmacol Ther 183 1-86
[10]  
Delling G(2007)Cell cycle-dependent Rho GTPase activity dynamically regulates cancer cell motility and invasion in vivo Biol Cell 99 67-1502